| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 5,4 k € | -97.8% | 242,9 k € | +33286.4% | -732,0 € | -100.5% | 159,5 k € | +27.9% | 124,7 k € | -19.9% | 155,7 k € | -22.4% | 200,6 k € | +243.7% | 58,4 k € | -13.9% | 67,8 k € | -3.4% | 70,2 k € | -82.3% | 397,1 k € | -34.2% | 603,7 k € | +2.8% | 587,1 k € | +39.5% | 420,8 k € | -6.3% | 449,0 k € | -18.6% | 551,3 k € | +0.6% | 547,9 k € | -20.3% | 687,6 k € | |
| EBITDA | 869,2 € | -99.6% | 239,7 k € | +8012.6% | -3,0 k € | -101.9% | 156,0 k € | +31.6% | 118,5 k € | -19.9% | 148,0 k € | -22.0% | 189,6 k € | +300.8% | 47,3 k € | -21.3% | 60,2 k € | -5.0% | 63,4 k € | -64.6% | 179,0 k € | -44.6% | 323,0 k € | +18.6% | 272,3 k € | +56.9% | 173,6 k € | +12.0% | 155,0 k € | -47.4% | 295,0 k € | -13.8% | 342,1 k € | -30.0% | 488,5 k € | |
| Operating profit | -69,3 k € | -143.2% | 160,4 k € | +264.2% | -97,7 k € | -261.7% | 60,4 k € | +924.5% | 5,9 k € | -83.9% | 36,6 k € | -61.9% | 96,1 k € | +485.6% | -24,9 k € | -59.2% | -15,7 k € | -34.9% | -11,6 k € | -110.4% | 111,6 k € | -28.8% | 156,7 k € | +25.0% | 125,4 k € | +166.7% | 47,0 k € | +24.4% | 37,8 k € | -81.0% | 198,5 k € | -24.8% | 264,0 k € | -35.7% | 410,5 k € | |
| Profit/loss | -79,0 k € | -172.0% | 109,7 k € | +209.6% | -100,1 k € | -287.4% | 53,4 k € | +1086.5% | -5,4 k € | -157.6% | 9,4 k € | -85.7% | 65,5 k € | +399.3% | -21,9 k € | -62.9% | -13,4 k € | +5.7% | -14,2 k € | -131.9% | 44,6 k € | -56.3% | 102,2 k € | +38.3% | 73,9 k € | +1205.0% | 5,7 k € | -74.9% | 22,6 k € | -78.7% | 106,1 k € | -35.9% | 165,3 k € | -38.3% | 267,9 k € | |
| Equity | 437,3 k € | -15.3% | 516,3 k € | +27.0% | 406,6 k € | -19.8% | 506,7 k € | +11.8% | 453,3 k € | -1.2% | 458,7 k € | +2.1% | 449,3 k € | +17.1% | 383,9 k € | -75.1% | 1,5 M € | -0.9% | 1,6 M € | -9.3% | 1,7 M € | +2.7% | 1,7 M € | -2.2% | 1,7 M € | +2.6% | 1,7 M € | +0.3% | 1,7 M € | -13.3% | 1,9 M € | +21.2% | 1,6 M € | -2.2% | 1,6 M € | |
| Total assets | 1,5 M € | +58.4% | 969,7 k € | -3.6% | 1,0 M € | -8.7% | 1,1 M € | -12.7% | 1,3 M € | -5.2% | 1,3 M € | -6.1% | 1,4 M € | +6.8% | 1,3 M € | -18.0% | 1,6 M € | -3.7% | 1,7 M € | -27.8% | 2,3 M € | +1.5% | 2,3 M € | +2.7% | 2,2 M € | -1.6% | 2,3 M € | -1.7% | 2,3 M € | -6.7% | 2,5 M € | +1.1% | 2,4 M € | -3.3% | 2,5 M € | |
| Cash | — | 4,9 k € | — | 5,9 k € | +232.2% | 1,8 k € | -79.5% | 8,6 k € | — | — | 7,8 k € | -68.3% | 24,6 k € | -73.0% | 91,3 k € | +9.1% | 83,6 k € | +94.2% | 43,1 k € | -23.0% | 55,9 k € | -53.4% | 120,1 k € | -7.7% | 130,1 k € | +42.0% | 91,6 k € | -40.3% | 153,5 k € | |||||||
| Debts | 1,1 M € | +154.0% | 431,0 k € | -27.7% | 595,9 k € | +1.4% | 587,5 k € | -26.4% | 797,9 k € | -7.4% | 862,1 k € | -10.0% | 957,6 k € | +2.5% | 934,6 k € | +1258.0% | 68,8 k € | -41.7% | 118,1 k € | -80.4% | 603,7 k € | -0.6% | 607,3 k € | +18.6% | 512,1 k € | -13.2% | 590,2 k € | -7.6% | 638,9 k € | +17.3% | 544,7 k € | -37.3% | 868,2 k € | -5.1% | 915,2 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 3,9 | 5 | 6,4 | 5,5 | 5,9 | 5,1 | 3,9 | 4,5 | ||||||||||||||||||
Public limited company · Maarkedal · incorporated on 20/12/1993
Public limited company loss-making in the latest fiscal year. Cash position declining (-15.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SEE INVEST is a Public limited company incorporated in 1993. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Maarkedal.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette